Trinity Biotech plc

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-16 pm EDT			5-day change	1st Jan Change
1.57 ^USD	+2.61%		-4.85%	-26.81%

05:20pm	European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	MT
May. 14	European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	MT

Trinity Biotech plc Announces Resignation of Peter Coyne as Non-Executive Director

June 07, 2018 at 11:44 am EDT

Trinity Biotech plc announced that effective June 5, 2018, Mr. Peter Coyne, resigned as Non-Executive Director of the company.

Latest news about Trinity Biotech plc

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	11:20am	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	May. 14	MT
Trinity Biotech Secures Additional Orders For TrinScreen HIV Rapid Test Product	May. 13	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	May. 10	MT
Trinity Biotech Announces the Appointment of Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development	May. 08	CI
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday	May. 07	MT
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	May. 06	MT
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	May. 03	MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	May. 02	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	Apr. 25	MT
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	Apr. 23	MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	Apr. 18	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Apr. 12	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
Transcript : Trinity Biotech plc, Q4 2023 Earnings Call, Apr 04, 2024	Apr. 04
Trinity Biotech plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 04	CI
Trinity Biotech plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	Mar. 27	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	Mar. 13	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	Mar. 11	MT

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-19 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
TRINITY BIOTECH PLC	-26.81%	14.48M
BIOMÉRIEUX	-4.57%	12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.35%	8.1B
DIASORIN S.P.A.	+8.91%	5.87B
LANTHEUS HOLDINGS, INC.	+30.81%	5.52B
AUTOBIO DIAGNOSTICS CO., LTD.	-7.42%	4.29B
10X GENOMICS, INC.	-54.27%	3.16B
ANDON HEALTH CO., LTD.	+14.44%	2.72B
VITROLIFE AB	-2.21%	2.37B
MYRIAD GENETICS, INC.	+28.53%	2.23B

Diagnostic & Testing Substances